These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2154084)

  • 21. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
    Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G
    J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simian AIDS ELISA: sensitivity, specificity and predictive values based on a comparison with Western blot technique.
    Spinner A; Sutjipto S
    Lab Anim Sci; 1988 Oct; 38(5):568-72. PubMed ID: 2848151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing specific retrovirus-free breeding colonies of macaques: an approach to primary screening and surveillance.
    Lerche NW; Yee JL; Jennings MB
    Lab Anim Sci; 1994 Jun; 44(3):217-21. PubMed ID: 7933966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in vaccine development against SIV and HIV.
    Bolognesi DP
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):390-4. PubMed ID: 1690288
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of feline leukemia virus vaccines.
    Legendre AM
    J Am Vet Med Assoc; 1994 Jul; 205(1):28. PubMed ID: 7928542
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccination against feline retrovirus infections].
    Horzinek MC
    Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental infection of African green monkeys and cynomolgus monkeys with a SIVAGM strain isolated from a healthy African green monkey.
    Honjo S; Narita T; Kobayashi R; Hiyaoka A; Fujimoto K; Takasaka M; Sakakibara I; Mukai R; Ishikawa K; Ohta Y
    J Med Primatol; 1990; 19(1):9-20. PubMed ID: 2160015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of SIV from sooty mangabey monkeys.
    Hirsch VM; Dapolito G; McGann C; Olmsted RA; Purcell RH; Johnson PR
    J Med Primatol; 1989; 18(3-4):279-85. PubMed ID: 2547963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal epithelial cells and Langerhans cells are targets for infection by the immunosuppressive type D retrovirus simian AIDS retrovirus serotype 1.
    Lackner AA; Schiødt M; Armitage GC; Moore PF; Munn RJ; Marx PA; Gardner MB; Lowenstine LJ
    J Med Primatol; 1989; 18(3-4):195-207. PubMed ID: 2547957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection.
    Stebbings R; Berry N; Stott J; Hull R; Walker B; Lines J; Elsley W; Brown S; Wade-Evans A; Davis G; Cowie J; Sethi M; Almond N
    Virology; 2004 Dec; 330(1):249-60. PubMed ID: 15527850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
    Dis Markers; 1990; 8(1):37-8. PubMed ID: 2155735
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigen capture assay for detection of simian type D retroviruses in cell cultures and plasma samples.
    Tsai CC; Yarnall M; Follis KE; Benveniste RE
    Lab Anim Sci; 1989 Nov; 39(6):554-9. PubMed ID: 2480476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review.
    King NW; Chalifoux LV; Ringler DJ; Wyand MS; Sehgal PK; Daniel MD; Letvin NL; Desrosiers RC; Blake BJ; Hunt RD
    J Med Primatol; 1990; 19(2):109-18. PubMed ID: 2160016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.
    Warren JT; Dolatshahi M
    J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110
    [No Abstract]   [Full Text] [Related]  

  • 38. [Simian AIDS virus: review].
    Brack M
    Zentralbl Veterinarmed B; 1989 Dec; 36(10):721-45. PubMed ID: 2559560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Review: Acquired immunodeficiency syndrome of man (AIDS) and of primates (SAIDS)].
    Trautwein G
    Dtsch Tierarztl Wochenschr; 1987 Feb; 94(2):77-9. PubMed ID: 3032555
    [No Abstract]   [Full Text] [Related]  

  • 40. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.